Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (221-230 of 594) with videos related to

Pageof 60
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinomaXiao-chun Xu, J Jack Lee, Tsung-Teh Wu, et al.
Cancer|October 10, 2013
Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinomaDa-Tian Bau, Scott M Lippman, Enping Xu, et al.
Journal of the National Cancer Institute|February 26, 2016
ResponseDenis L Jardim, Maria Schwaederle, J Jack Lee, et al.
Pest Management Science|June 23, 2018
Chronic toxicity of clothianidin, imidacloprid, chlorpyrifos, and dimethoate to Apis mellifera L. larvae reared in vitroPingli Dai, Cameron J Jack, Ashley N Mortensen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
The BATTLE to personalize lung cancer prevention through reverse migrationKathryn A Gold, Edward S Kim, J Jack Lee, et al.
Cancer|October 1, 2008
Genetic variations in cell-cycle pathway and the risk of oral premalignant lesionsYuanqing Ye, Scott M Lippman, J Jack Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studiesRajul K Jain, J Jack Lee, Chaan Ng, et al.
Cancer|March 27, 2018
Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trialKathryn A Gold, Merrill S Kies, William N William, et al.
The Journal of Surgical Research|May 20, 2023
Surgeons of the Future: A Novel Screening Tool for High-School StudentsLyndon C Walsh, Dawen Sui, Robert S D Higgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worseRajul K Jain, J Jack Lee, David Hong, et al.
Pageof 60

Showing results (221-230 of 594) with videos related to

Sort By:
Pageof 60
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinomaXiao-chun Xu, J Jack Lee, Tsung-Teh Wu, et al.
Cancer|October 10, 2013
Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinomaDa-Tian Bau, Scott M Lippman, Enping Xu, et al.
Journal of the National Cancer Institute|February 26, 2016
ResponseDenis L Jardim, Maria Schwaederle, J Jack Lee, et al.
Pest Management Science|June 23, 2018
Chronic toxicity of clothianidin, imidacloprid, chlorpyrifos, and dimethoate to Apis mellifera L. larvae reared in vitroPingli Dai, Cameron J Jack, Ashley N Mortensen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
The BATTLE to personalize lung cancer prevention through reverse migrationKathryn A Gold, Edward S Kim, J Jack Lee, et al.
Cancer|October 1, 2008
Genetic variations in cell-cycle pathway and the risk of oral premalignant lesionsYuanqing Ye, Scott M Lippman, J Jack Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Change in tumor size by RECIST correlates linearly with overall survival in phase I oncology studiesRajul K Jain, J Jack Lee, Chaan Ng, et al.
Cancer|March 27, 2018
Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trialKathryn A Gold, Merrill S Kies, William N William, et al.
The Journal of Surgical Research|May 20, 2023
Surgeons of the Future: A Novel Screening Tool for High-School StudentsLyndon C Walsh, Dawen Sui, Robert S D Higgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worseRajul K Jain, J Jack Lee, David Hong, et al.
Pageof 60